Emerging Treatments in Neurogastroenterology: Relamorelin: A Novel Gastrocolokinetic Synthetic Ghrelin Agonist

Neurogastroenterology and Motility - United Kingdom
doi 10.1111/nmo.12490
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Immunotherapy in Inflammatory Bowel Disease: Novel and Emerging Treatments

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2018English

Emerging Treatments in Eating Disorders

Neurotherapeutics
NeurologyPharmacology
2017English

Synthetic Toll Like Receptor-4 (TLR-4) Agonist Peptides as a Novel Class of Adjuvants

PLoS ONE
Multidisciplinary
2012English

Effects of Ghrelin Agonist and Antagonist on Endogenous Desacyl-Ghrelin Content in the Brain Limbical Structures Under Psychoemotional Stress in Rats

Reviews on Clinical Pharmacology and Drug Therapy
2017English

Recent Advances and Emerging Treatments

BMJ
2006English

Emerging Treatments in Recurrent and Metastatic Colorectal Cancer

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2013English

Crystal Structure of Human Estrogen-Related Receptor Α in Complex With a Synthetic Inverse Agonist Reveals Its Novel Molecular Mechanism

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2007English

Drug Therapy in Obesity: A Review of Current and Emerging Treatments

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2020English

Analysis and Clinical Findings of Cases Positive for the Novel Synthetic Cannabinoid Receptor Agonist MDMB-CHMICA

Clinical Toxicology
MedicineToxicology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy